Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2020 Apr 26;8(8):2761–2768.e16. doi: 10.1016/j.jaip.2020.04.030

Table II. Allergens that were most frequently detectable by chip technology in the patient group with mastocytosis and in individuals of the control cohort.

Allergen Mastocytosis (n = 42) Nonadvanced mastocytosis (n = 34) Advanced mastocytosis (n = 8) Controls (n = 42)
Ves v 5 16.7 17.6 12.5 16.7
Bet v 1 11.9 14.7 0 9.5
Aln g 1 9.5 11.8 0 7.1
Cor a 1.0401 7.1 8.8 0 7.1
Phl p 1 9.5 11.8 0 14.3
Phl p 5 7.1 8.8 0 14.3
Ole e 1 7.1 8.8 0 7.1

Values represent % of patients. Sera obtained from 42 patients with mastocytosis and 42 controls without mastocytosis were analyzed for specific IgE by the chip. Results for the chip-positive cases are shown as a percentage of all patients in each group. Allergen designation: Aln g 1, pathogenesis-related protein (PR-10) from alder; Bet v 1, PR-10, pollen from birch; Cor a 1.0401, PR-10 from hazelnut; Ole e 1, common olive group 1 (olive); Phl p 1, beta-expansin, pollen from timothy grass; Phl p 5, pollen from timothy grass; Ves v 5, antigen 5, venom from yellow jacket.